Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1<i>H</i>)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119Dean A. Wacker, Jeffrey A. Robl, Ying Wang et al.|Journal of Medicinal Chemistry|2014Cited by 46
Exploring co-mutations in CML and ph(+) b-ALL with ABL1 variants: Correlations with survival and treatment response.Kaitlyn C. Dykes, Tiffany Tanaka, Ayad Hamdan et al.|Blood|2025Cited by 0